000 01335 a2200361 4500
005 20250511175020.0
264 0 _c19931018
008 199310s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.1992.tb51623.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCollen, D
245 0 0 _aFibrin-specific fibrinolysis.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cDec 1992
300 _a259-71 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aFibrin
_xmetabolism
650 0 4 _aFibrin Fibrinogen Degradation Products
_xmetabolism
650 0 4 _aFibrinolysin
_xmetabolism
650 0 4 _aFibrinolysis
650 0 4 _aHumans
650 0 4 _aModels, Biological
650 0 4 _aPlasminogen
_xmetabolism
650 0 4 _aPlasminogen Activator Inhibitor 1
_xmetabolism
650 0 4 _aPlasminogen Activator Inhibitor 2
_xmetabolism
650 0 4 _aTissue Plasminogen Activator
_xmetabolism
650 0 4 _aUrokinase-Type Plasminogen Activator
_xmetabolism
650 0 4 _aalpha-Macroglobulins
_xmetabolism
700 1 _aLijnen, H R
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 667
_gp. 259-71
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.1992.tb51623.x
_zAvailable from publisher's website
999 _c1291552
_d1291552